Select your location:
Select your location:
An important biomarker for non-invasive prenatal testing (NIPT) and liquid biopsy, circulating cell-free DNA (ccfDNA) is easily obtainable through a simple blood draw. ccfDNA from plasma has the ability to provide a breadth of information to researchers.
Blood collection, stabilization and ccfDNA extraction for reliable downstream assay performance
Check out our poster presented at the AACR Virtual Meeting II
Learn about the non-crosslinking stabilization chemistry in the PAXgene Blood ccfDNA Tube and how other tubes may impact analytical sensitivity in downstream reactions.
Five minute read on how to perform multimodal analysis from a single blood sample. Learn how to extract and analyze ccfDNA and additional analytes like RNA from CTCs or gDNA from a single sample of blood collected in the PAXgene Blood ccfDNA Tube*.
Researchers in the field of non-invasive prenatal testing analyze fetal DNA present among maternal ccfDNA from blood of a pregnant woman to determine the risk that the fetus will be born with certain genetic abnormalities.
Liquid biopsy is a minimally-invasive method of collecting a patient biofluid sample to test for biomarkers of disease. Liquid biopsy is commonly used for many applications in cancer research.
Click here to learn more about QIAGEN's manual and automated Sample to Insight workflows for liquid biopsy and cancer research applications.
*The PAXgene Blood ccfDNA Tube is for Research Use Only. Not for use in diagnostic procedures.
